A pilot study comparing myelin measurements from myelin water imaging and 11C-PIB PET in multiple sclerosis

Irene M Vavasour1, Nasim Vafai2, Philippe Beauchemin3

  • 1Radiology, University of British Columbia, Vancouver, Canada; International Collaboration on Repair Discoveries (ICORD), University of British Columbia, Vancouver, Canada.

Insights

Myelin water fraction (MWF) and Pittsburgh compound B (PiB) imaging both detect myelin loss in multiple sclerosis (MS). This study found MWF and PiB provide distinct information regarding myelin changes in MS lesions.

Area of Science:

  • Neuroimaging
  • Biomarker Discovery
  • Multiple Sclerosis Research

Background:

  • Multiple Sclerosis (MS) is characterized by demyelination.
  • Accurate measurement of myelin damage is crucial for MS research and treatment.
  • MRI-based myelin water fraction (MWF) and PET-based Pittsburgh compound B (PiB) are potential imaging biomarkers for myelin.

Discussion:

  • This pilot study investigated the differences and correlations between MWF and PiB binding in MS lesions compared to normal-appearing white matter (NAWM).
  • Both MWF and PiB binding were reduced in MS lesions, indicating myelin compromise.
  • A modest correlation was observed between MWF and PiB binding within subjects.

Key Insights:

  • MRI-derived MWF and PET-derived PiB binding are both sensitive to myelin loss in MS lesions.
  • MWF and PiB binding capture different aspects of myelin pathology in MS.
  • These imaging techniques offer complementary information for characterizing MS-related demyelination.

Outlook:

  • Further research with larger cohorts is needed to validate these findings.
  • Combining MWF and PiB imaging may provide a more comprehensive assessment of myelin integrity in MS.
  • These biomarkers hold potential for monitoring disease progression and treatment response in MS.

Related Concept Videos